findmyKOL

Adam Brufsky, MD, PhD

Enriched profile

Professor of Medicine; Associate Division Chief, Division of Hematology/Oncology, University of Pittsburgh School of Medicine · University of Pittsburgh School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Pittsburgh, PA · Northeast · United StatesSpecialtySpecialistFocusAdvanced Breast Cancer Therapies+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1996–2026

Adam Brufsky is Professor of Medicine; Associate Division Chief, Division of Hematology/Oncology, University of Pittsburgh School of Medicine at University of Pittsburgh School of Medicine. OpenAlex indexes 1,001 publications with 37,097 citations (h-index 95); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 15 Oct 2026

Adam M. Brufsky, md, is Professor of Medicine at University of Pittsburgh School of Medicine / UPMC Hillman Cancer Center. The public record shows 1,001 publications with 37,097 citations (h-index 95), centered on Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 38 companies, 5 NIH-funded awards (1996–2026).

  • Most recent indexed publication: 2026 · JCO precision oncology
  • Top research focus: Advanced Breast Cancer Therapies
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 38 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer5 trialsEndometrial Neoplasms1 trialCarcinoma, Lobular1 trial

Research focus

OpenAlex concept fingerprint
Advanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyCancer Genomics and Diagnostics

Drugs & molecules

across trials, industry payments and publications
Ibrancegeneric · PalbociclibClinical trials1Industry payments110Publications7Nerlynxgeneric · NeratinibClinical trials2Industry payments12Publications2Lynparzageneric · OlaparibClinical trials1Industry payments3Publications5Trodelvygeneric · SacituzumabClinical trials—Industry payments160Publications3Enhertugeneric · TrastuzumabClinical trials—Industry payments34Publications4Orserdugeneric · ElacestrantClinical trials—Industry payments18Publications1Verzeniogeneric · AbemaciclibClinical trials—Industry payments13Publications1Femarageneric · LetrozoleClinical trials—Industry payments3Publications4PaclitaxelClinical trials3Industry payments—Publications2Piqraygeneric · AlpelisibClinical trials1Industry payments4Publications—CarboplatinClinical trials1Industry payments—Publications2Perjetageneric · PertuzumabClinical trials—Industry payments2Publications1

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trials—Industry payments195Myriad Genetic Laboratories, Inc.Clinical trials—Industry payments154Pfizer Inc.Clinical trials—Industry payments120AstraZeneca Pharmaceuticals LPClinical trials—Industry payments73Lilly USA, LLCClinical trials—Industry payments27AstraZeneca UK LimitedClinical trials—Industry payments25Stemline Therapeutics Inc.Clinical trials—Industry payments20Novartis Pharmaceuticals CorporationClinical trials—Industry payments19Puma Biotechnology, Inc.Clinical trials—Industry payments18Ge HealthcareClinical trials—Industry payments11Seagen Inc.Clinical trials—Industry payments11Eli Lilly and CompanyClinical trials—Industry payments8Genentech, Inc.Clinical trials—Industry payments7Daiichi Sankyo Inc.Clinical trials—Industry payments5Sanofi-Aventis U.S. LLCClinical trials—Industry payments5Genentech USA, Inc.Clinical trials—Industry payments4Eisai Inc.Clinical trials—Industry payments3R-Pharm US LLCClinical trials—Industry payments3TerSera Therapeutics LLCClinical trials—Industry payments3Amgen Inc.Clinical trials—Industry payments2Blueprint Medicines CorporationClinical trials—Industry payments2Exelixis Inc.Clinical trials—Industry payments2Janssen Biotech, Inc.Clinical trials—Industry payments2Menarini Silicon Biosystems, Inc.Clinical trials—Industry payments2Merck Sharp & Dohme LLCClinical trials—Industry payments2Tempus AI, IncClinical trials—Industry payments2AgendiaClinical trials1Industry payments—Daehwa Pharmaceutical Co., Ltd.Clinical trials1Industry payments—Daiichi Sankyo Company LTDClinical trials—Industry payments1Eisai Co., Ltd.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,001publications

Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.

37,097citations

Total citations across indexed works.

95h-index

Hirsch index (OpenAlex). i10-index 355.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
38companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1996–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    81.3%
    Aromatase Inhibitor62.5%
    Anastrozole62%Letrozole29%Exemestane10%
    Part D≥109 patients
    Estrogen Agonist/Antagonist9.5%
    Tamoxifen Citrate100%
    Part D≥27 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    8.8%
    Serotonin-3 Receptor Antagonist5.4%
    Ondansetron Hcl60%Ondansetron Odt40%
    Part D<11 patients
    Corticosteroid2.3%
    Prednisone100%
    Part D≥12 patients

    + 1 more class in this area

  • Nervous system

    6.1%
    Phenothiazine4.4%
    Prochlorperazine Maleate100%
    Part D≥14 patients
    Gabapentinoids1.7%
    Gabapentin100%
    Part D<11 patients
All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 15 Oct 2026

5 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Hope S. Rugo90Steffi Oesterreich76Adrian V. Lee75Nancy E. Davidson69Sara A. Hurvitz68Sandra M. Swain64Joyce O’Shaughnessy63Margaret Rosenzweig61Rachel C. Jankowitz60Charles E. Geyer60Priya Rastogi56Rohit Bhargava55Norman Wolmark55Denise A. Yardley53Louis Fehrenbacher51Peter C. Lucas48Eleftherios P. Mamounas47David J. Dabbs44Debu Tripathy44Antonio C. Wolff42Vered Stearns41Rekha Gyanchandani38Aju Mathew38Roisín M. Connolly37Soonmyung Paik37Peter A. Kaufman33Lynn McRoy33Richard Piekarz33Shannon Puhalla33Michelle A. Rudek32Rachel M. Layman32Susan M. Sereika31Priscilla F. McAuliffe31Aditya Bardia29José Pablo Leone29Hanna Bandos29Benjamin Li28Kenneth Lundström28Ryan J. Hartmaier28Vladimir N. Uversky28

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/adam-brufsky-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
  • ResearchGate

    researchgate.net/profile/Adam-Brufsky

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/adam-brufsky-0304b7190

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • LinkedIn

    linkedin.com/in/adam-brufsky-1672772b1

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/DR8_b1liNeS

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • Instagram

    instagram.com/reel/DPOkqGckZOu

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Other

    themedicinementors.libsyn.com/going-further-together-with-dr-adam-brufsky

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themedicinementors.libsyn.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Medical Oncology and Bone Marrow Transplantation, Dana-Farber Cancer Institute

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • Residency

    Internal Medicine, Brigham and Women's Hospital, Harvard Medical School

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • MD

    University of Connecticut School of Medicine

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • PhD

    University of Connecticut School of Medicine

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • AB

    Dartmouth College

    1984
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • Board Certification

    Internal Medicine, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • Board Certification

    Medical Oncology, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Magee-Women's Cancer Program, UPMC Hillman Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • Co-Director

    Comprehensive Breast Cancer Center, UPMC

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
  • Principal Investigator

    Pittsburgh Breast Cancer Consortium (U.S. Department of Defense-funded)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmc.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.